<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>620</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15627979</PubmedId>
            <Abstract>Borna disease virus (BDV) infection of the central nervous system (CNS) leads to severe neurological symptoms in susceptible MRL mice. The disease is mainly mediated by CD8+ T cells specific for the immunodominant epitope TELEISSI in the BDV nucleoprotein. In this study, TELEISSI/MHC class I tetramers were used to directly visualize antigen-specific CD8+ T cells. We found that on average approximately 30% of the ex vivo analyzed CD8+ T cells in the CNS of diseased mice were specific for TELEISSI. Unexpectedly, the frequency of tetramer-reactive brain-derived CD8+ T cells doubled following overnight culture in the absence of antigen. The majority of CD8+ T cells showed enhanced tetramer binding without up-regulation of T cell receptor surface expression. The frequency of IFN-gamma-secreting CD8+ T cells after antigen-specific stimulation was higher in overnight cultures than in freshly isolated BDV-specific brain lymphocytes, and enhanced tetramer binding correlated with elevated sensitivity to lower levels of peptide antigen in cytotoxicity assays. These results indicate that the functional avidity of virus-specific CD8+ T cells was down-modulated in vivo. Thus, quantification of tissue-infiltrating CD8+ T cells by the tetramer technique must be interpreted with caution as it may underestimate the real frequency of antigen-specific CD8+ T cells.</Abstract>
            <ArticleYear>2005</ArticleYear>
            <ArticlePages>487-97</ArticlePages>
            <ArticleTitle>The functional avidity of virus-specific CD8+ T cells is down-modulated in Borna disease virus-induced immunopathology of the central nervous system.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Engelhardt</LastName>
                    <ForeName>Karin R</ForeName>
                </Author>
                <Author>
                    <LastName>Richter</LastName>
                    <ForeName>Kirsten</ForeName>
                </Author>
                <Author>
                    <LastName>Baur</LastName>
                    <ForeName>Karen</ForeName>
                </Author>
                <Author>
                    <LastName>Staeheli</LastName>
                    <ForeName>Peter</ForeName>
                </Author>
                <Author>
                    <LastName>Hausmann</LastName>
                    <ForeName>JÃ¼rgen</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Virology, Institute of Medical Microbiology and Hygiene, University of Freiburg, Freiburg, Germany.</Affiliations>
            <ArticleChemicalList>H-2 Antigens;H-2K(K) antigen;Peptides;Receptors, Antigen, T-Cell;Interferon-gamma</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Borna Disease(diagnosis; immunology; pathology); Borna disease virus(immunology); CD8-Positive T-Lymphocytes(immunology; metabolism); Central Nervous System(immunology; pathology; virology); Down-Regulation; H-2 Antigens(immunology); Interferon-gamma(metabolism); Mice; Peptides; Receptors, Antigen, T-Cell(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>35</Volume>
                <Issue>2</Issue>
                <Title>European journal of immunology</Title>
                <Issn>0014-2980</Issn>
                <MedlineTa>Eur J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>TELEISSI</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TELEISSI</LinearSequence>
                        <StartingPosition>129</StartingPosition>
                        <EndingPosition>136</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q01552.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>12455</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 488</LocationOfData>
                <EpitopeId>63436</EpitopeId>
                <ReferenceStartingPosition>129</ReferenceStartingPosition>
                <ReferenceEndingPosition>136</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Text</LocationOfData>
                        <TCellId>5843</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000627</OrganismId>
                                <Age>10-17 days</Age>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>125</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>12455</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>mouse adapted BDV</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intracerebral</Route>
                                <DoseSchedule>One dose of 10 microliters</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were immunized with infected rat brain homogenate.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Central nervous system (CNS)</CellTissueType>
                            <CellType>Mononuclear cell</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>L cells-Fibroblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>125</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>TELEISSI</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TELEISSI</LinearSequence>
                                        <StartingPosition>129</StartingPosition>
                                        <EndingPosition>136</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q01552.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>12455</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Incubating the effector cells in the absence of antigen overnight increases the number of spot-forming cells in eight out of 10 mice analyzed.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Text</LocationOfData>
                        <TCellId>5841</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000627</OrganismId>
                                <Age>10-17 days</Age>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>125</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>12455</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>mouse adapted BDV</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intracerebral</Route>
                                <DoseSchedule>One dose of 10 microliters</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were immunized with infected rat brain homogenate.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Central nervous system (CNS)</CellTissueType>
                            <CellType>Mononuclear cell</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>125</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>TELEISSI</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TELEISSI</LinearSequence>
                                        <StartingPosition>129</StartingPosition>
                                        <EndingPosition>136</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q01552.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>12455</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.33</QuantitativeMeasurement>
                            <AssayComments>The fraction of stained CD8+ cells increases from an average of 33% to 58% upon incubating the effector cells in the absence of antigen overnight.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>5842</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000627</OrganismId>
                                <Age>10-17 days</Age>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>125</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>12455</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>mouse adapted BDV</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intracerebral</Route>
                                <DoseSchedule>One dose of 10 microliters</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were immunized with infected rat brain homogenate.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Central nervous system (CNS)</CellTissueType>
                            <CellType>Mononuclear cell</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>L cells-Fibroblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>125</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>TELEISSI</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TELEISSI</LinearSequence>
                                        <StartingPosition>129</StartingPosition>
                                        <EndingPosition>136</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q01552.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>12455</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>In contrast to the tetramer staining, incubating the effector cells in the absence of antigen overnight does not have a consistent effect on the cytotoxic T cell activity.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

